left-arrow right-arrow pinterest facebook google_plus linkedin

Other Trials

The following listings are our current trials. If you have questions or want to learn more about the trial, please contact us and provide the Methodist Health System Trial Code listed with the description.


AFT-39

Status: Recruiting | Phase Not Applicable 

Official Title: Electronic patient reporting of symptoms during outpatient cancer treatment: A U.S. national randomized controlled trial (the “PRO-TECT” trial)

Study Purpose: To determine if having patients report their symptoms of cancer treatment electronically on weekly basis will benefit patients more than patient report symptoms at appointments, and gather perspectives on reporting symptoms online or over the phone from patients and staff. Learn more.


Head and Neck Cancer Registry

Status: Recruiting | Phase Not Applicable 

Official Title: Integrated Cancer Repository for Cancer Research (iCaRe2)

Study Purpose: To gather information, tissue, and blood samples from patients that have been diagnosed with head and neck cancer to be used for future research and analysis. Learn more.


Pharmatech 516-001

Status: Available | Phase Ib

Official Title: A Phase I/Ib Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies.

Study Purpose: To identify how much MGCD516 can safely be administered to subjects, how much study drug is absorbed after taking MFCD516 capsules orally and how quickly the study drug is cleared from the blood stream. Learn more.


Thyroid Cancer Registry

Status: Recruiting | Phase Not Applicable 

Official Title: Development and Implementation of the Thyroid Cancer Collaborative Registry (TCCR)

Study Purpose: To gather information, tissue, and blood samples from patients that have been diagnosed with thyroid cancer to be used for future research and analysis. Learn more.